Claudin 13 example sentences

"Claudin 13" Example Sentences

1. Claudin 13 expression is often dysregulated in cancer.
2. The study focused on the role of claudin 13 in gastric cancer.
3. Researchers investigated the interaction between claudin 13 and other tight junction proteins.
4. Claudin 13 deficiency may lead to impaired barrier function.
5. Targeting claudin 13 could be a novel therapeutic strategy.
6. Immunohistochemistry revealed high levels of claudin 13 in the tumor samples.
7. The expression of claudin 13 was significantly lower in the diseased tissue.
8. Further research is needed to elucidate the exact function of claudin 13.
9. Claudin 13 is a transmembrane protein crucial for epithelial integrity.
10. Disruption of claudin 13 may contribute to disease pathogenesis.
11. Antibodies targeting claudin 13 are currently under development.
12. The study confirmed the prognostic significance of claudin 13 expression.
13. Low claudin 13 levels were associated with poor patient survival.
14. Claudin 13 plays a vital role in maintaining tissue homeostasis.
15. The mechanism of action of claudin 13 is not fully understood.
16. Genetic variations in claudin 13 may increase disease susceptibility.
17. Claudin 13 is a potential biomarker for early disease detection.
18. This review summarizes the current knowledge on claudin 13.
19. Future studies should explore the potential of claudin 13-targeted therapies.
20. The results suggest a correlation between claudin 13 and disease progression.
21. Aberrant claudin 13 expression is a hallmark of many cancers.
22. Claudin 13 interacts with other proteins to form tight junctions.
23. In this model, claudin 13 knockdown led to increased permeability.
24. Overexpression of claudin 13 was observed in the experimental group.
25. The role of claudin 13 in inflammation remains to be elucidated.
26. We hypothesize that claudin 13 plays a role in immune regulation.
27. Claudin 13 expression is influenced by various environmental factors.
28. Interestingly, claudin 13 levels were not affected by treatment.
29. The downregulation of claudin 13 was statistically significant.
30. Claudin 13 could serve as a valuable diagnostic tool.
31. A novel approach utilizes claudin 13 as a drug target.
32. Clinical trials are underway to evaluate claudin 13-based therapies.
33. The impact of claudin 13 on patient outcomes is significant.
34. Studies suggest a potential link between claudin 13 and drug resistance.
35. Monitoring claudin 13 levels may help guide treatment decisions.
36. Dysregulation of claudin 13 contributes to tumorigenesis.
37. Claudin 13 is a member of the claudin family of proteins.
38. The localization of claudin 13 was determined using immunofluorescence.
39. Claudin 13 expression is tightly regulated during development.
40. Claudin 13 knockout mice exhibit altered barrier function.
41. Understanding claudin 13 is crucial for developing effective treatments.
42. More research is warranted to explore the clinical implications of claudin 13.
43. The potential of claudin 13 as a therapeutic target is promising.
44. Claudin 13 has emerged as a key player in cancer biology.
45. Recent advancements shed new light on the role of claudin 13.
46. Novel approaches are being developed to target claudin 13 effectively.
47. The discovery of claudin 13's role has transformed our understanding.
48. Future therapies might directly modulate claudin 13 activity.
49. This innovative strategy leverages claudin 13 for personalized medicine.
50. Improved diagnostics based on claudin 13 detection are anticipated.